Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,148.20
(
0.53%
)
S&P ASX All Technology
2,413.60
(
0.96%
)
Brent Oil
74.295
(
-0.04%
)
US Dollar vs AUD
1.52052
(
0.02%
)
Bitcoin
26,743.38
(
-0.29%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) Financials

EOLS

Evolus Inc

8.83
-0.22 (-2.43%)
Upgrade to Real-Time

Evolus Inc. (EOLS) Fundamentals
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary of 900 kilodalton or kDa, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance.
SHARE INFORMATION
Market CapUS$ 493,520,529
Shares Outstanding56,922,783
Float42,130,000
Percent Float74.01%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 41,721,000
Latest Fiscal EPSUS$ -0.26
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions301
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months3,978,355
Institutional Holdings Percent72.2%
Institutional Sold Previous 3 Months3,974,025
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months917,134
Insider Holdings Percent18.1
Insider Sold Previous 3 Months4,122,738
Insider Shares Owned10,232,352
TRADING INFO
52 Week HighUS$ 14.30
52 Week LowUS$ 6.51
52 Week High ChangeUS$ -34.07
21 Day Moving AverageUS$ 9.4052
21 Day Extended Moving AverageUS$ 9.2278
50 Day Moving AverageUS$ 8.8284
50 Day Extended Moving AverageUS$ 9.0338
200 Day Moving AverageUS$ 8.6926
200 Day Extended Moving AverageUS$ 8.9889
10 Day Average Volume443,514
20 Day Average Volume563,221
30 Day Average Volume499,798
50 Day Average Volume448,998
Alpha0.001824
Beta1.6383
Standard Deviation0.269697
R20.106607
7 Day Price ChangeUS$ -0.31
7 Day Percent Change-3.45%
21 Day Price ChangeUS$ -1.63
21 Day Percent Change-15.83%
30 Day Price ChangeUS$ -0.03
30 Day Percent Change-0.34%
Month to Date Price ChangeUS$ -0.38
Month to Date Percent Change-4.2%
Quarter to Date Price ChangeUS$ 0.21
Quarter to Date Percent Change2.48%
180 Day Price ChangeUS$ 1.33
180 Day Percent Change18.12%
200 Day Price ChangeUS$ 1.20
200 Day Percent Change16.06%
Year to Date Price ChangeUS$ 1.16
Year to Date Percent Change15.45%

Evolus Inc. (EOLS) Key Ratios

PROFITABILITY
EBIT Margin-39.6%
EBITDA Margin-36.8%
Pre-Tax Profit Margin-116.5%
Profit Margin Count-0.35%
Gross Margin65.0%
Profit Margin TOT-0.35%
INCOME STATEMENTS
RevenueUS$ 41,721,000
Revenue Per ShareUS$ 0.7329
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-7.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio2.10
Leverage Ratio0.00
Quick Ratio1.40
Long Term Debt To Capital0.91
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 565,162,047
Price to Sales3.15
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book-167.90
Price To Cash Flow-5.80
PE Low Last 5 Years0.00
Price to Tangible Book-7.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.80
Invoice Turnover4.10
Assets Turnover0.80
Return Assets-37.65
Return on Equity-223.38
Return on Capital-55.58

Evolus Inc. (EOLS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEODavid Moatazedi
Employees174
Last Audit-
CIK0001570562
IndustryPharmaceuticals
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address520 Newport Center Drive,Suite 1200
Suite 1200
Newport Beach, CA 92660
Websitehttps://www.evolus.com
Facsimile-
Telephone+1 949 284-4555
EmailIR@Evolus.com
Your Recent History
NASDAQ
EOLS
Evolus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230602 01:22:31